A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03743051 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia; Cancer
Non Small Cell Lung Cancer

Interventions

DRUG: Anamorelin Hydrochloride
DRUG: Placebo Oral Tablet

Sponsor

Helsinn Healthcare SA